LLY vs. MU: Eli Lilly vs. Micron Stock Comparison
How do Eli Lilly (LLY) and Micron (MU) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Eli Lilly (LLY) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Micron (MU) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.
| Profile Item | LLY | MU |
|---|---|---|
| Name | Eli Lilly and Company | Micron Technology Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Information Technology |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences | Semiconductors & Semiconductor Equipment |
| GICS Industry | Pharmaceuticals | Semiconductors & Semiconductor Equipment |
| GICS Sub-Industry | Pharmaceuticals | Semiconductors |
| Market Capitalization | 1,206.07 billion USD | 780.68 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | June 1, 1972 | June 1, 1984 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | LLY | MU |
|---|---|---|
| Total Return (1Y) | 52.36% | 208.53% |
| Total Return (3Y, Annualized) | 34.18% | 115.89% |
| Total Return (5Y, Annualized) | 41.08% | 58.28% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
Micron (MU) has a highly aggressive beta of 2.44, indicating much higher sensitivity to broad-market moves, while Eli Lilly (LLY) is defensive at 0.40 and tends to be less market-sensitive — a wide gap in beta profiles.
| Metric | LLY | MU |
|---|---|---|
| Volatility (1Y, Annualized) | 35.34% | 83.85% |
| Beta (5Y) | 0.40 | 2.44 |
| Max Drawdown (5Y) | -34.48% | -57.63% |
| Avg. Volume (3M) | 2.52M | 27.63M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | LLY | MU |
|---|---|---|
| Sharpe Ratio (1Y) | 1.36 | 2.44 |
| Sortino Ratio (1Y) | 2.29 | 3.87 |
Profitability
ROE (TTM)
Both companies show strong equity returns, but Micron (MU) at 88.26% is the standout with ROE above its industry range; Eli Lilly (LLY) at 86.02% also sits in the top quartile.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
86.02%
- Max
- 109.18%
- LLY
- 86.02%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
MU
Semiconductors & Semiconductor Equipment industry group
88.26%
- MU
- 88.26%
- Max
- 52.82%
- Q3
- 22.26%
- Median
- 10.58%
- Q1
- 1.29%
- Min
- -16.89%
Net Margin (TTM)
Eli Lilly (LLY) at 31.90% keeps the most of each sales dollar — above its industry’s net margin range — and Micron (MU) at 63.80% also retains a top-quartile share.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
31.90%
- LLY
- 31.90%
- Max
- 18.05%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
MU
Semiconductors & Semiconductor Equipment industry group
63.80%
- MU
- 63.80%
- Max
- 63.80%
- Q3
- 28.36%
- Median
- 11.44%
- Q1
- 0.90%
- Min
- -37.77%
Operating Margin (TTM)
Micron (MU) at 80.68% shows unusually strong operating efficiency — above its industry’s operating margin range — and Eli Lilly (LLY) at 53.66% also operates in the top quartile.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
53.66%
- Max
- 83.12%
- LLY
- 53.66%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
MU
Semiconductors & Semiconductor Equipment industry group
80.68%
- MU
- 80.68%
- Max
- 58.66%
- Q3
- 30.23%
- Median
- 15.91%
- Q1
- 7.54%
- Min
- -25.74%
Profitability Metrics
| Metric | LLY | MU |
|---|---|---|
| ROE (TTM) | 86.02% | 88.26% |
| ROA (TTM) | 21.06% | 44.56% |
| Net Margin (TTM) | 31.90% | 63.80% |
| Operating Margin (TTM) | 53.66% | 80.68% |
| Gross Margin (TTM) | 83.63% | 80.72% |
Growth
Revenue Growth
Micron (MU) at 256.33% clears its industry range for revenue growth, far stronger top-line momentum than Eli Lilly (LLY) at 44.70%, which is closer to a typical peer reading.
EPS Growth
Both companies show strong earnings momentum, but Micron (MU) at 879.31% is the standout with EPS growth above its industry range; Eli Lilly (LLY) at 95.99% also sits in the top quartile.
Growth Metrics
| Metric | LLY | MU |
|---|---|---|
| Revenue Growth (YoY) | 44.70% | 256.33% |
| Revenue Growth (3Y CAGR) | 31.69% | 104.65% |
| EPS Growth (YoY) | 95.99% | 879.31% |
| EPS Growth (3Y CAGR) | 51.71% | -- |
Financial Strength
Current Ratio (MRQ)
Micron (MU) at 3.31 keeps current ratio within its industry’s typical mid-range, while Eli Lilly (LLY) at 1.39 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.39
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- LLY
- 1.39
- Min
- 0.10
MU
Semiconductors & Semiconductor Equipment industry group
3.31
- Max
- 10.33
- Q3
- 5.62
- Median
- 3.33
- MU
- 3.31
- Q1
- 2.35
- Min
- 1.03
Debt / Equity (MRQ)
Micron (MU) at 0.04 keeps leverage in the lower quartile, while Eli Lilly (LLY) at 1.23 sits in the higher-leverage quartile.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.23
- Max
- 1.42
- LLY
- 1.23
- Q3
- 0.65
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
MU
Semiconductors & Semiconductor Equipment industry group
0.04
- Max
- 1.46
- Q3
- 0.65
- Median
- 0.27
- Q1
- 0.04
- MU
- 0.04
- Min
- 0.00
Financial Strength Metrics
| Metric | LLY | MU |
|---|---|---|
| Current Ratio (MRQ) | 1.39 | 3.31 |
| Debt / Equity (MRQ) | 1.23 | 0.04 |
| Net Debt / EBITDA | 0.96 | -0.35 |
Dividends
Dividend Yield (TTM)
Micron (MU) at 0.09% pays an industry-typical yield; Eli Lilly (LLY) at 0.49% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.49%
- LLY
- 0.49%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
MU
Semiconductors & Semiconductor Equipment industry group
0.09%
- Max
- 1.37%
- Q3
- 0.65%
- MU
- 0.09%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Micron (MU) at 0.71% keeps its payout in the industry’s typical band, while Eli Lilly (LLY) at 21.71% pays out more than any of its peers — the most stretched cover in its group.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
21.71%
- LLY
- 21.71%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
MU
Semiconductors & Semiconductor Equipment industry group
0.71%
- Max
- 49.64%
- Q3
- 21.71%
- MU
- 0.71%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | LLY | MU |
|---|---|---|
| Dividend Yield (TTM) | 0.49% | 0.09% |
| Dividend Payout Ratio (TTM) | 21.71% | 0.71% |
Valuation
P/E Ratio (TTM)
Micron (MU) at 9.28 sits in the cheaper P/E ratio quartile, while Eli Lilly (LLY) at 43.95 sits in the richer quartile — a clear split in what investors pay for each dollar of trailing earnings.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
43.95
- Max
- 85.34
- LLY
- 43.95
- Q3
- 43.46
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
MU
Semiconductors & Semiconductor Equipment industry group
9.28
- Max
- 110.34
- Q3
- 66.81
- Median
- 37.02
- Q1
- 23.96
- MU
- 9.28
- Min
- 8.12
P/S Ratio (TTM)
On P/S ratio, both Eli Lilly (LLY) at 13.95 and Micron (MU) at 5.86 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
13.95
- Max
- 58.18
- Q3
- 25.77
- LLY
- 13.95
- Median
- 7.30
- Q1
- 3.01
- Min
- 0.01
MU
Semiconductors & Semiconductor Equipment industry group
5.86
- Max
- 21.42
- Q3
- 12.27
- MU
- 5.86
- Median
- 5.76
- Q1
- 2.73
- Min
- 0.00
P/B Ratio (MRQ)
Micron (MU) at 5.64 sits near its industry’s typical P/B ratio, while Eli Lilly (LLY) at 29.96 prices above its benchmark range — LLY looks rich relative to book.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
29.96
- LLY
- 29.96
- Max
- 13.53
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
MU
Semiconductors & Semiconductor Equipment industry group
5.64
- Max
- 14.06
- Q3
- 7.44
- MU
- 5.64
- Median
- 4.29
- Q1
- 2.30
- Min
- 0.20
Valuation Metrics
| Metric | LLY | MU |
|---|---|---|
| P/E Ratio (TTM) | 43.95 | 9.28 |
| P/S Ratio (TTM) | 13.95 | 5.86 |
| P/B Ratio (MRQ) | 29.96 | 5.64 |
| Free Cash Flow Yield (TTM) | 0.77% | 3.73% |